US · AHCO
AdaptHealth Corp.
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Plymouth Meeting, PA 19462
- Website
- adapthealth.com
Price · as of 2025-12-31
$13.17
Market cap 1.24B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $31.05 | +135.76% |
| Intrinsic Value(DCF) | $4.32 | -67.2% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | $9.94 | $11,859.70 | $24,817.36 | $1.71 | $5.61 |
| 2019 | $16.54 | $34.38 | $552.24 | $0.00 | $0.00 |
| 2020 | $37.17 | $81.18 | $75,295.58 | $0.00 | $0.00 |
| 2021 | $15.51 | $66.00 | $10,562.93 | $0.00 | $166.65 |
| 2022 | $13.80 | $38.32 | $826.87 | $0.00 | $14.58 |
| 2023 | $10.85 | $22.27 | $48.76 | $0.00 | $0.00 |
| 2024 | $10.48 | $31.59 | $0.00 | $0.00 | $6.66 |
| 2025 | $9.64 | $31.05 | $0.37 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates AdaptHealth Corp.'s (AHCO) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $31.05
- Current price
- $13.17
- AI upside
- +135.76%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$4.32
-67.2% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| AHCO | AdaptHealth Corp. | $13.17 | 1.24B | +136% | -67% | — | — | -19.73 | 0.86 | 0.40 | 2.75 | — | -1.18 | 17.52% | 5.74% | -2.18% | -4.27% | 7.18% | -1.50% | 0.12 | 1.76 | 1.02 | 0.67 | 0.16 | -18525.00% | -49.00% | -696.00% | 16.84% | 0.84 | 8.45% | 0.00% | 0.00% | 148.90% | 7.43 | 6.31 | 0.43 | 0.97 |
| AMPH | Amphastar Pharmaceuticals… | $20.23 | 929.61M | +167% | -56% | -25% | -32% | — | 1.25 | 1.36 | 5.01 | — | 4.41 | 49.46% | 19.50% | 13.63% | 0.00% | 13.00% | 0.00% | 0.06 | 5.51 | 4.02 | 2.70 | -0.82 | -3366.00% | -165.00% | -10000.00% | 0.00% | 0.00 | 0.00% | 0.00% | — | 63.32% | 5.32 | — | 1.04 | 2.35 |
| BBNX | Beta Bionics, Inc. | $12.63 | 560.55M | +248% | +7,672% | — | — | -6.93 | 1.76 | 5.06 | -4.11 | — | 1.76 | 55.40% | -71.50% | -73.02% | -40.26% | -236.00% | -30.60% | 0.04 | — | 8.66 | 7.64 | 0.26 | -7895.00% | 5394.00% | -10000.00% | 0.00% | 0.00 | 0.00% | 0.00% | 0.00% | 0.00% | -4.20 | — | 3.00 | 6.28 |
| CNMD | CONMED Corporation | $46.00 | 1.42B | +64% | -60% | -94% | -57% | 30.20 | 1.38 | 1.03 | 12.53 | — | -3.99 | 53.87% | 9.47% | 3.42% | 4.72% | 4.69% | 2.03% | 0.81 | 4.19 | 2.14 | 0.92 | 4.49 | -6455.00% | 518.00% | -195.00% | 10.62% | 0.54 | 8.22% | 1.74% | 52.60% | 7.88% | 17.02 | 14.68 | 1.61 | 1.97 |
| CVAC | CureVac N.V. | $4.66 | 1.05B | +3,460% | -35% | +67% | +15,600% | 3.05 | 0.84 | 1.09 | 0.65 | — | 0.87 | 80.23% | 33.20% | 30.30% | 31.46% | 74.77% | 23.99% | 0.06 | — | 7.28 | 7.16 | -2.11 | -16102.00% | 89554.00% | -12582.00% | 14.31% | 1.41 | 41.31% | 0.00% | 0.00% | 14.10% | 0.77 | 1.64 | 0.25 | 2.92 |
| ESTA | Establishment Labs Holdin… | $78.70 | 2.29B | -26% | +32% | — | — | -44.15 | 95.73 | 10.68 | -66.58 | — | 181.85 | 69.32% | -18.48% | -24.19% | -133.25% | -49.45% | -14.51% | 0.12 | -1.54 | 3.04 | 1.86 | 2.22 | -4267.00% | 2714.00% | -2314.00% | -2.53% | -0.62 | -82.02% | 0.00% | 0.00% | 9.21% | -55.92 | -38.31 | 10.34 | 4.85 |
| HCSG | Healthcare Services Group… | $21.77 | 1.53B | +60% | -59% | -54% | -44% | 27.23 | 3.15 | 0.88 | 21.88 | 51.55 | 3.80 | 13.03% | 2.64% | 3.21% | 11.69% | 11.87% | 7.28% | 0.05 | 30.72 | 3.38 | 3.16 | -2.09 | 5283.00% | 708.00% | 46875.00% | 8.65% | 0.85 | 39.11% | 0.00% | 0.00% | 8.04% | 29.44 | 10.27 | 0.78 | 6.81 |
| INMD | InMode Ltd. | $13.75 | 871.18M | +312% | -24% | +30% | -77% | 9.40 | 1.29 | 2.38 | 3.06 | — | 1.29 | 78.54% | 23.05% | 25.33% | 13.53% | 56.67% | 12.09% | 0.02 | — | 9.88 | 8.55 | -2.61 | -3644.00% | -616.00% | -3615.00% | 9.56% | 1.21 | 65.78% | 0.00% | 0.00% | 30.54% | 3.98 | 4.03 | 0.92 | 9.96 |
| IRMD | IRadimed Corporation | $103.53 | 1.32B | -46% | -36% | — | -72% | 33.89 | 7.51 | 8.90 | 26.33 | 305.02 | 7.79 | 76.94% | 29.99% | 26.26% | 24.31% | 59.56% | 20.20% | 0.00 | — | 8.84 | 7.38 | -2.29 | 1111.00% | 1171.00% | 22283.00% | 2.70% | 3.01 | 60.30% | 2.10% | 71.10% | 2.77% | 27.31 | 34.04 | 8.19 | 37.09 |
| STAA | STAAR Surgical Company | $19.90 | 982.38M | +92% | -59% | -70% | — | -44.58 | 2.27 | 2.87 | -123.99 | — | 2.28 | 76.32% | -4.02% | -6.44% | -5.16% | -6.20% | -4.05% | 0.10 | — | 5.23 | 4.41 | 18.43 | -19535.00% | -264.00% | 11338.00% | -0.85% | 0.22 | -3.77% | 0.00% | 0.00% | 0.17% | -56.24 | -92.48 | 2.26 | 5.87 |
| UFPT | UFP Technologies, Inc. | $210.58 | 1.62B | -43% | +6% | -65% | +13% | 23.04 | 3.71 | 2.61 | 14.60 | 146.78 | 18.38 | 28.27% | 15.32% | 11.33% | 17.82% | 14.23% | 10.64% | 0.32 | 9.42 | 1.19 | 0.65 | 0.99 | 1570.00% | 1950.00% | 3871.00% | 5.02% | 0.58 | 14.70% | 0.00% | 0.00% | 4.92% | 18.29 | 21.39 | 2.80 | 5.53 |
About AdaptHealth Corp.
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.
- CEO
- Suzanne Foster
- Employees
- 10.5K
- Beta
- 1.75
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($4.32 ÷ $13.17) − 1 = -67.2% (DCF, example).